Increasing plasma lysophosphatidylcholine levels in patients with regular 
dextran sulfate lipoprotein apheresis.

Graessler, Juergen; Schuhmann, Kai; Shevchenko, Andrej; Kopprasch, S; Ban, Ryan; Bergmann, S; Bornstein, Stefan; Hohenstein, Bernd; Julius, U

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Increasing plasma lysophosphatidylcholine levels in patients with regular dextran sulfate lipoprotein apheresis.

MPS-Authors

/persons/resource/persons219654

Schuhmann, Kai
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

/persons/resource/persons218972

Shevchenko, Andrej
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

Bornstein, Stefan
Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Graessler, J., Schuhmann, K., Shevchenko, A., Kopprasch, S., Ban, R., Bergmann, S., Bornstein, S., Hohenstein, B., & Julius, U. (2015). Increasing plasma lysophosphatidylcholine levels in patients with regular dextran sulfate lipoprotein apheresis. Atherosclerosis. Supplements, 18, 170-175.

引用: https://hdl.handle.net/21.11116/0000-0001-044C-6

要旨

Previously we found a highly significant increase of phosphatidylethanolamines (PE) in response to acute lipoprotein apheresis (LA) with whole blood dextran sulfate adsorption (DSA) in contrast to the overall tendency of reduction of lipid metabolites of all lipid classes in post-apheresis plasma. Therefore, the aim of the present study was to analyze long-term modifications of the plasma lipidomic profile in patients with repeated DSA apheresis.